The Amarillo VA Health Care System (AVAHCS) is seeking Service Disabled Veteran Owned Small Business (SDVOSB) or Veteran Owned Small Business (VOSB) sources capable of meeting the requirement listed below. The acquisition will be accomplished using commercial item procedures in accordance with FAR Part 12. NOTE: TO QUALIFY SDVOSB AND VOSB VENDORS MUST BE CERTIFIED IN THE VA VENDOR INFORMATION PAGES (VIP) DATABASE. The North American Industry Classification System (NAICS) is 621511. Any SDVOSB or VOSB firms who wish to identify their interests and capability to provide this product must provide product specifications, performance and delivery information by notifying the Contract Specialist no later than NOON PM Central Time, October 6, 2016. Notification shall be e-mailed to Lula Hill, at
[email protected]. DISCLAIMER This Source Sought Notice is issued solely for information and planning purposes only and does not constitute a solicitation. All information received in response to this Notice that is marked as proprietary will be handled accordingly. In accordance with the Federal Acquisition Regulation, responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this Notice. SCOPE: 1. The vendor shall provide all personnel, equipment, tools, materials, supervision, other items and non-personal services necessary to perform gene expression assay, Oncotype DX testing as defined in the Performance Work Statement. The Vendor shall perform to the standards in the contract. 2. The Vendor shall provide AVAHCS services for: a. Oncotype DX testing- Breast (CPT code 81519) b. Oncotype DX testing- Colon (CPT code 81525) c. Oncotype DX testing-Prostate (CPT code 81479) 3. The Vendor shall develop and maintain an effective quality control program to ensure services are performed in accordance with this PWS. a. The Vendors quality control program is the means by which the contractor work complies with the requirement of the contract. 4. The Vendor shall develop and implement procedures to identify, prevent and ensure non-recurrence of defective services. 5. The Vendor shall agree to participate in an on-going Quality Assurance surveillance plan. 6. Vendor shall provide specimen transportation kit boxes and all applicable forms necessary to perform the specific testing. a. AVHCS shall provide the information as requested on the Oncotype DX Assay Requisition Form. 7. The Vendor shall send the patients results to the lab department listed on the Requisition Form via fax. a. The Vendor provides reports that summarize the findings of the patients test. A detailed Oncotype DX assay report is generated for each patient, with assay results provided as a Recurrence Score result (0-100). b. The Vendor's report includes Clinical Experience for women with node-negative, ER-positive breast cancer and post-menopausal women with node-positive, hormone receptor positive breast cancer and all other results available to the commercial market place to the AVAHCS P&LMS. ACCREDITATION: 1. The Vendor shall provide all licenses, permits, be able to meet accreditation and certificates required by law.